Business Wire

Gilead Sciences Launches Age Positively Initiative to Address Unique Challenges of Aging Population Living with HIV

Jaa

Gilead Sciences, Inc. (NASDAQ: GILD) today announced it is providing $17.6 million in grants to 30 organizations in the United States through the Gilead HIV Age Positively initiative. This effort aims to enhance the lives of individuals aging with HIV by focusing in three priority areas: improving care coordination, increasing resources for better well-being, and educating and informing policies that impact people living and aging with HIV. Estimates suggest that by 2030, more than 80 percent of people living with HIV will face at least one age-related medical condition, compared to just 29 percent in 2010.

“Community partners who work tirelessly to improve the lives of people living with HIV inspire us all,” said Amy Flood, Senior Vice President of Public Affairs at Gilead. “Gilead understands science alone is not enough to help people lead longer, healthier lives. That’s why we work together with advocates, healthcare providers and community organizations to identify the unique challenges people aging with HIV experience and dedicate resources to maximize impact in communities across the country.”

The HIV Age Positively grantees include longtime advocacy organizations, who are now better equipped to provide life-saving services to their communities, as well as newer organizations that add to the overall effort to strengthen care and services for this growing population. Each grantee was selected for their unique ability to articulate interventions that have the potential to transform the quality of life for people aging with HIV.

“Anyone who lived through the 1980s and ‘90s remembers the generation of Americans we lost to the HIV epidemic and the heroic work this community has done together to increase the life expectancy of people living with HIV," said Kelsey Louie, Chief Executive Officer, Gay Men’s Health Crisis. "As they have in the past, Gilead brought experts together, listened to what our community needed and identified the organizations best equipped to tackle specific problems. Funding from HIV Age Positively is going to help long-term survivors combat loneliness, obtain access to the resources and support they need and create better, more personalized healthcare. Everyone deserves to live a long and healthy life and this program is going to help make that possible for countless people living and aging with HIV."

Aging people living with HIV face a unique set of challenges, and healthcare providers and the broader community of allies need additional resources to meet their needs. As part of the HIV Age Positively effort, Gilead convened an advisory board of experts with deep insights into the subject of aging with HIV.

“The advisory board created a space for leaders to come together and address these unmet needs of people aging with HIV,” said Stephen Karpiak, Ph.D., Senior Director of Research at ACRIA Center on HIV and Aging at GMHC, and a member of the advisory board. “By spotlighting and uplifting potential interventions, we aim to shine a bright new light on the too often forgotten and marginalized community of people aging with HIV: the challenges they face, the resources they need and the support they deserve.”

The advisory board members included healthcare providers, researchers and community advocates from AIDS Project Los Angeles (APLA), Test Positive Awareness Network (TPAN), the University of Pittsburgh, Boston University, ACRIA, University of California, San Diego, HTW Campaign, SAGE and the HIV Vaccine Trials Network.

This group determined that addressing the interrelated challenges within our healthcare system and the general HIV community, like stigma, loneliness and better coordination of care, is essential in reaching a viable solution to these challenges.

Recipient grantees include:

  • Abounding Prosperity – Dallas, TX
  • The AIDS Institute, Inc. – Nationwide
  • AIDS Project – New Haven, CT
  • American Indian Community House, Inc. – Nationwide
  • APLA Health & Wellness – California Statewide
  • The Association of Nurses in AIDS Care – Nationwide
  • Borrego Community Health Foundation – Southern California
  • Cascade AIDS Project – Oregon and Southwest Washington
  • Center for Health Justice, Inc. – Los Angeles, CA
  • Community Healthcare Network, Inc. – New York, NY
  • Family Health Centers of San Diego, Inc. – San Diego, CA
  • Gay Men’s Health Crisis – Nationwide
  • HealthHIV – Nationwide
  • Hektoen Institute for Medical Research – Chicago, IL
  • Legal Aid Service of Broward County, Inc. – Broward County, FL
  • Montefiore Medical Center – New York, NY
  • My Brother’s Keeper – Mississippi (Statewide)
  • New Orleans Advocates for GLBT Elders (NOAGE) – New Orleans, LA
  • Professional Association of Social Workers in HIV & AIDS – Nationwide
  • Project Open Hand – San Francisco, CA
  • Regents of the University of California at San Diego – San Diego, CA
  • SAGE – Nationwide
  • San Francisco AIDS Foundation – San Francisco, CA
  • Shanti Project, Inc. – San Francisco, CA
  • Thrive SS, Inc. – Nationwide
  • Test Positive Awareness Network, Inc.– Chicago, IL
  • University of California, San Francisco – San Francisco, CA
  • University of Maryland Baltimore Foundation Inc. – Baltimore, MD
  • Us Helping Us - People Into Living, Inc. – Washington, DC
  • Washington Hospital Center Corporation – Washington, DC

For more information visit: https://www.gilead.com/purpose/partnerships-and-community/hiv-age-positively

About Gilead Sciences

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.

Contact information

Media
Chris Ridley
(650) 235-2220

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Knopp Biosciences Presents Positive Preclinical Data for Lead Neonatal Epilepsy Drug Candidate at 2019 Antiepileptic Drug and Device Trials XV Conference24.5.2019 17:00:00 EESTTiedote

Knopp Biosciences LLC, a privately held drug discovery and development company focused on delivering breakthrough treatments for inflammatory and neurological diseases of high unmet need, today presented in vitro and in vivo data for the company’s lead molecule for the targeted treatment of KCNQ2-neonatal epileptic encephalopathy (KCNQ2-NEE) at the Antiepileptic Drug and Device Trials XV Conference in Miami, Florida. KCNQ2-NEE, a rare infant genetic epilepsy, results from mutations in genes encoding the Kv7.2/Kv7.3 ion channel, leading to frequent seizures and profound developmental delay. The preclinical data were presented by Steven Dworetzky, Ph.D., Knopp’s Chief Scientific Officer, a longtime Kv7 researcher who led the group that first cloned the Kv7.2 and Kv7.3 genes during his former tenure with the Bristol-Myers Squibb Co. Dr. Dworetzky presented results demonstrating the in vitro nanomolar activity of KB-3061 and its significant seizure protection in the maximal electroshock mo

Accelerate Your Business in South Korea Through 2019 K-Startup Grand Challenge24.5.2019 13:20:00 EESTTiedote

Entrepreneurs from across the globe should set their sights on participating in the 2019 K-Startup Grand Challenge. Supported by the Ministry of SMEs and Startups and National IT Industry Promotion Agency (NIPA) of South Korea, the initiative provides invaluable support and comprehensive resources to early age startups. Applications for the K-Startup Grand Challenge are currently being accepted through June 14, 2019. In order to advance in the program, teams must pass a regional audition. A judging panel of startup ecosystem experts and Korean accelerators will select 40 teams to participate in an enriching 3.5 month-long acceleration program in Korea. The selected teams will have exclusive access to free office space at the Startup Campus in Pangyo Techno Valley, one-on-one mentoring, information sessions, coaching on Korean and Asian business culture and the chance to attend insightful seminars on accounting regulations to tax laws, patents and more. Opportunities for networking with

New Investigational Clinical Data for Ipsen’s Oncology Products in 11 Solid Tumor Types to Be Presented at 2019 ASCO Annual Meeting24.5.2019 08:00:00 EESTTiedote

Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced that new data from clinical studies on investigational uses of cancer medicines cabozantinib (Cabometyx®), liposomal irinotecan (Onivyde®), and lanreotide autogel (Somatuline®, marketed as Somatuline Depot® in the United States) will be presented at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting. The meeting takes place in Chicago, Illinois, U.S., 31 May–4 June 2019; data featuring Ipsen medicines includes: New data from the Phase 3 CELESTIAL trial on the association of adverse events with efficacy outcomes for cabozantinib in patients with advanced hepatocellular carcinoma Overview of the Phase 3 COSMIC-312 trial of cabozantinib in combination with atezolizumab vs sorafenib in patients with advanced hepatocellular carcinoma who have not received previous systemic anticancer therapy First Phase 2 data from the CaboGIST study (trial 1317) from the European Organization for Research and Treatment of

The Posiflex Group Showcases an Ecosystem of Connected Solution Endpoints with IoT Remote Monitoring at Computex 201924.5.2019 04:00:00 EESTTiedote

For the Computex 2019 show, The Posiflex Group is featuring leading solution technology from the family of brands as a fully Serviced IoT Ecosystem. Solution end points include: Connected Modular Kiosks, POS Terminals, and Digital Signage solutions from Posiflex and KIOSK Information Systems Smart Medical Displays with gesture controls from Portwell Connected Gaming Solutions with Player Tracking Technology from Portwell subsidiary, Ganlot The booth display is based on common field service endpoints represented in a European Manor Destination Resort setting. Field solutions for an array of vertical market applications include QSR ordering, cinema ticketing, fashion retail customer loyalty, interactive signage, hotel / medical center check-in and bill pay, as well as casino gaming technology. This year, in addition to their renowned POS product suite, Posiflex will be featuring newly introduced Modular Kiosk platforms (co-designed by KIOSK and Posiflex), which are configure-to-order sta

Audi China President Thomas Owsianski to Keynote at CES Asia 201923.5.2019 23:00:00 EESTTiedote

The Consumer Technology Association (CTA)TM today announced that Thomas Owsianski, president of Audi China, will deliver a keynote address at the upcoming CES Asia 2019. Now in its fifth year, CES Asia will run June 11-13, 2019 at the Shanghai New International Expo Centre (SNIEC) in Shanghai, China. Thomas Owsianski’s keynote is scheduled for 4 PM, Tuesday, June 11, where he will unveil Audi’s vision in transforming mobility from a driving experience to a digital adventure. Mr. Owsianski joined the top management team of Audi China in August 2018 and was named President in October 2018. “Audi has been at the forefront of driving global transformation in the automotive industry through their breakthrough advancements in technology,” said Karen Chupka, executive vice president, CES. “Innovation has revolutionized the transportation experience, and we welcome Mr. Owsianski to the CES Asia stage to share Audi’s vision for the future of global mobility.” Throughout Asia and beyond, technol

ITechLaw Publishes New Book and Opens Global Public Comment Period on Draft Principles for Responsible Artificial Intelligence23.5.2019 22:11:00 EESTTiedote

The International Technology Law Association (ITechLaw) has published Responsible AI: A Global Policy Framework, a new book that provides an in-depth review and eight discussion principles that address some of the hottest technology and moral issues of responsible development, deployment and use of artificial intelligence. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190523005752/en/ ITechLaw releases new book, Responsible AI: A Global Policy Framework, and opens public comment period. (Photo: Business Wire) Written by a multi-disciplinary group of 54 technology law experts, industry representatives and researchers from 16 countries, the book offers an actionable framework built on the following principles: Ethical Purpose and Societal Benefit, Accountability, Transparency and Explainability, Fairness and Non-discrimination, Safety and Reliability, Open Data and Fair Competition, Privacy, and AI and Intellectual Property.

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme